Aberdeen Asset Management PLC UK held its position in Fresenius Medical Care Corporation (NYSE:FMS) during the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 8,700 shares of the company’s stock at the end of the 2nd quarter. Aberdeen Asset Management PLC UK’s holdings in Fresenius Medical Care Corporation were worth $420,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Pacer Advisors Inc. acquired a new stake in shares of Fresenius Medical Care Corporation during the second quarter worth about $179,000. FFT Wealth Management LLC acquired a new stake in shares of Fresenius Medical Care Corporation during the second quarter worth about $201,000. RMB Capital Management LLC acquired a new stake in shares of Fresenius Medical Care Corporation during the first quarter worth about $220,000. HPM Partners LLC acquired a new stake in shares of Fresenius Medical Care Corporation during the second quarter worth about $221,000. Finally, GHP Investment Advisors Inc. acquired a new stake in shares of Fresenius Medical Care Corporation during the second quarter worth about $224,000. 2.61% of the stock is currently owned by institutional investors.

Shares of Fresenius Medical Care Corporation (NYSE:FMS) opened at 48.86 on Friday. Fresenius Medical Care Corporation has a 12 month low of $38.05 and a 12 month high of $50.22. The firm has a market cap of $29.99 billion, a price-to-earnings ratio of 21.06 and a beta of 0.48. The company has a 50-day moving average price of $47.05 and a 200-day moving average price of $46.00.

Fresenius Medical Care Corporation (NYSE:FMS) last posted its quarterly earnings results on Tuesday, August 1st. The company reported $0.48 earnings per share for the quarter, missing analysts’ consensus estimates of $0.53 by ($0.05). Fresenius Medical Care Corporation had a return on equity of 11.57% and a net margin of 7.06%. The firm had revenue of $4.47 billion for the quarter, compared to analyst estimates of $5.20 billion. During the same period last year, the company posted $0.96 earnings per share. The firm’s quarterly revenue was up 11.1% compared to the same quarter last year. Analysts forecast that Fresenius Medical Care Corporation will post $2.34 earnings per share for the current fiscal year.

A number of equities research analysts have recently commented on FMS shares. DZ Bank AG reaffirmed a “buy” rating on shares of Fresenius Medical Care Corporation in a research report on Monday, August 7th. Nord/LB reaffirmed a “buy” rating on shares of Fresenius Medical Care Corporation in a research report on Wednesday, June 28th. BidaskClub lowered Fresenius Medical Care Corporation from a “strong-buy” rating to a “buy” rating in a research report on Monday, July 24th. Zacks Investment Research raised Fresenius Medical Care Corporation from a “hold” rating to a “buy” rating and set a $54.00 price target on the stock in a research report on Tuesday, July 11th. Finally, Royal Bank Of Canada reaffirmed a “hold” rating and set a $44.00 price target on shares of Fresenius Medical Care Corporation in a research report on Wednesday, July 5th. One analyst has rated the stock with a sell rating, five have given a hold rating and six have issued a buy rating to the company’s stock. The stock currently has an average rating of “Hold” and a consensus target price of $48.67.

TRADEMARK VIOLATION WARNING: This piece of content was first posted by Daily Political and is owned by of Daily Political. If you are accessing this piece of content on another site, it was illegally copied and reposted in violation of U.S. and international trademark and copyright legislation. The correct version of this piece of content can be accessed at https://www.dailypolitical.com/2017/09/22/fresenius-medical-care-corporation-fms-stake-maintained-by-aberdeen-asset-management-plc-uk.html.

About Fresenius Medical Care Corporation

Fresenius Medical Care AG & Co KGaA is a kidney dialysis company. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The Company’s segments include North America Segment, the Europe, Middle East and Africa (EMEA) Segment, the Asia-Pacific Segment and the Latin America Segment.

Institutional Ownership by Quarter for Fresenius Medical Care Corporation (NYSE:FMS)

Receive News & Ratings for Fresenius Medical Care Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care Corporation and related companies with MarketBeat.com's FREE daily email newsletter.